• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1950 - 1982年北欧国家的肺结节病。流行病学与临床表现。

Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture.

作者信息

Milman N, Selroos O

机构信息

Department of Pulmonary Medicine, Gentofte Hospital, Copenhagen, Denmark.

出版信息

Sarcoidosis. 1990 Mar;7(1):50-7.

PMID:2345819
Abstract

The review is based on studies from Denmark, Finland, Norway and Sweden during 1950-1982. In general sarcoidosis was slightly more frequent in females than in males, especially after 40 years of age. The majority of cases were diagnosed before 35 years; 59% had symptoms, 41% were found by chance. Radiological stage I was present in 50%, stage II in 35%, and stage III-IV in 14%. The prevalence was age dependent with maximum between 18-35 years, varying from 8-102/10(5) examined persons in Finland to 27 in Norway and 64 in Sweden. The incidence was likewise age related, being highest in 18- to 20-years-old males (57/10(5) examined persons/year); overall incidence varied from 14-15/10(5) examined persons/year in Denmark, Finland and Norway to 24 in Sweden. No definite change in incidence figures has occurred. The accumulated lifetime risk of acquiring sarcoidosis was identical in the two sexes up to 45 years of age, and then increased in females; at 65 years the risk was 1.6% in females and 1.2% in males based on the population examined.

摘要

该综述基于1950年至1982年间丹麦、芬兰、挪威和瑞典的研究。一般来说,结节病在女性中比在男性中略为常见,尤其是在40岁以后。大多数病例在35岁之前被诊断出来;59%有症状,41%是偶然发现的。放射学分期I期占50%,II期占35%,III-IV期占14%。患病率与年龄有关,在18至35岁之间最高,芬兰每10(5)名受检者中患病率为8至102例,挪威为27例,瑞典为64例。发病率同样与年龄相关,在18至20岁男性中最高(每年每10(5)名受检者中有57例);丹麦、芬兰和挪威的总体发病率为每年每10(5)名受检者中有14至15例,瑞典为24例。发病率数字没有明显变化。在45岁之前,两性患结节病的累积终生风险相同,之后女性风险增加;根据受检人群计算,65岁时女性风险为1.6%,男性为1.2%。

相似文献

1
Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture.1950 - 1982年北欧国家的肺结节病。流行病学与临床表现。
Sarcoidosis. 1990 Mar;7(1):50-7.
2
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.北欧国家癌症发病率趋势。北欧五个癌症登记处的合作研究。
Acta Pathol Microbiol Immunol Scand Suppl. 1986;288:1-151.
3
Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis.1950 - 1982年北欧国家的肺结节病。II. 病程与预后。
Sarcoidosis. 1990 Sep;7(2):113-8.
4
Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features.日本结节病的流行病学研究。发病率和患病率的近期趋势以及流行病学特征的变化。
Sarcoidosis. 1989 Sep;6(2):138-46.
5
Fatal poisoning in Nordic drug addicts in 2002.2002年北欧吸毒者中的致命中毒情况。
Forensic Sci Int. 2006 Jul 13;160(2-3):148-56. doi: 10.1016/j.forsciint.2005.09.004. Epub 2005 Nov 9.
6
Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.北欧47697名接受儿童癌症治疗患者的终身癌症发病率。
J Natl Cancer Inst. 2009 Jun 3;101(11):806-13. doi: 10.1093/jnci/djp104. Epub 2009 May 26.
7
Incidence and mortality of pancreatic cancer in the Nordic countries 1971-2000.1971 - 2000年北欧国家胰腺癌的发病率和死亡率
Acta Oncol. 2007;46(8):1064-9. doi: 10.1080/02841860701381234.
8
Childhood sarcoidosis in Denmark 1979-1994: incidence, clinical features and laboratory results at presentation in 48 children.1979 - 1994年丹麦儿童结节病:48例儿童发病时的发病率、临床特征及实验室检查结果
Acta Paediatr. 2004 Jan;93(1):30-6.
9
[Is there sarcoidosis in countries with a high prevalence of tuberculosis? (author's transl)].结核病高流行国家存在结节病吗?(作者译)
Z Erkr Atmungsorgane. 1977 Jul;149(1):67-74.
10
Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria.北欧国家青少年特发性关节炎的发病率。一项基于人群的研究,特别参考国际风湿病联盟(ILAR)和欧洲抗风湿病联盟(EULAR)标准的有效性。
J Rheumatol. 2003 Oct;30(10):2275-82.

引用本文的文献

1
[Sarcoidosis].[结节病]
Z Rheumatol. 2023 Jun;82(5):389-403. doi: 10.1007/s00393-023-01338-1. Epub 2023 Jun 1.
2
The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.皮肤结节病的演变格局:发病机制的新见解、临床面临的挑战和治疗的新领域。
Am J Clin Dermatol. 2022 Jul;23(4):499-514. doi: 10.1007/s40257-022-00693-0. Epub 2022 May 18.
3
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.注射用促肾上腺皮质激素治疗肺结节病:一项叙述性综述
Pulm Ther. 2022 Mar;8(1):43-55. doi: 10.1007/s41030-022-00181-0. Epub 2022 Feb 3.
4
Sex-Steroid Signaling in Lung Diseases and Inflammation.性类固醇信号在肺部疾病和炎症中的作用。
Adv Exp Med Biol. 2021;1303:243-273. doi: 10.1007/978-3-030-63046-1_14.
5
Management of Cardiac Sarcoidosis in 2020.2020年心脏结节病的管理
Arrhythm Electrophysiol Rev. 2020 Dec;9(4):182-188. doi: 10.15420/aer.2020.09.
6
Catch the rainbow: Prognostic factor of sarcoidosis.捕捉彩虹:结节病的预后因素。
Lung India. 2020 Sep-Oct;37(5):425-432. doi: 10.4103/lungindia.lungindia_380_19.
7
Radiologic Manifestations of Musculoskeletal Sarcoidosis.骨骼肌肉系统结节病的放射学表现。
Curr Rheumatol Rep. 2019 Feb 14;21(3):7. doi: 10.1007/s11926-019-0806-0.
8
Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study.韩国的结节病流行率和发病率:一项全国性基于人群的研究。
Respir Res. 2018 Aug 28;19(1):158. doi: 10.1186/s12931-018-0871-3.
9
Sarcoidosis mortality in Sweden: a population-based cohort study.瑞典的肉样瘤病死亡率:一项基于人群的队列研究。
Eur Respir J. 2018 Feb 21;51(2). doi: 10.1183/13993003.01815-2017. Print 2018 Feb.
10
Disease Burden and Variability in Sarcoidosis.结节病的疾病负担和变异性。
Ann Am Thorac Soc. 2017 Dec;14(Supplement_6):S421-S428. doi: 10.1513/AnnalsATS.201707-564OT.